Skip to Content

Allogene Therapeutics

ALLO

Buy $ALLO at eToro
Rank 3253
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Allogene Therapeutics - Key figures

Market cap 1.68 Billion
Revenue 205 Thousand
Profit -181,687,000
P/E Ratio No information
P/s Ratio 8181.7
Buy $ALLO at eToro

Allogene Therapeutics - Description

Allogene Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and markets genetically engineered allogeneic T-cell therapies for the treatment of cancer.

The company is headquartered in South San Francisco, California.